Page last updated: 2024-08-26

5'-adenylyl (beta,gamma-methylene)diphosphonate and Metabolic Syndrome

5'-adenylyl (beta,gamma-methylene)diphosphonate has been researched along with Metabolic Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashimoto, M; Kagota, S; Kubota, Y; Kunitomo, M; Nakamura, K; Nejime, N; Shinozuka, K; Tanaka, N; Yamamoto, R1

Other Studies

1 other study(ies) available for 5'-adenylyl (beta,gamma-methylene)diphosphonate and Metabolic Syndrome

ArticleYear
Dysfunction of purinergic regulation of sympathetic neurotransmission in SHR/NDmcr-cp (SHR-cp) rat.
    Clinical and experimental pharmacology & physiology, 2004, Volume: 31 Suppl 2

    Topics: 2-Chloroadenosine; Adenosine Triphosphate; Animals; Arteries; Electric Stimulation; In Vitro Techniques; Male; Metabolic Syndrome; Norepinephrine; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Agonists; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Purinergic P1; Receptors, Purinergic P2; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction

2004